Saturday, October 31, 2026

Franco And 4 Other Stocks Have Very High Payout Ratio

ViaNews Editorial Team

December 29, 2021

Franco And 4 Other Stocks Have Very High Payout Ratio

(VIANEWS) - Boston Properties (BXP), Oil (ODC), Progress Software Corporation (PRGS) are the highest payout ratio stocks on this list.

Here's the data we've collected of stocks with a high payout ratio up until now. The payout ratio in itself isn't a guarantee of a future good investment but it's an indicator of whether dividends are being paid and how the company chooses to distribute them.

When investigating a potential investment, the dividend payout ratio is a good statistic to know so here is a list of some companies with an above 30% payout ratio.

1. Boston Properties (BXP)

204.17% Payout Ratio

Boston Properties (NYSE: BXP) is the largest publicly-held developer and owner of Class A office properties in the United States, concentrated in five markets - Boston, Los Angeles, New York, San Francisco and Washington, DC.

Volume

Today's last reported volume for Boston Properties is 316240, 56.58% below its average volume of 728477.

As maintained by Morningstar, Inc., the next dividend payment is on Jun 28, 2021, the estimated forward annual dividend rate is 3.92 and the estimated forward annual dividend yield is 3.43%.

Boston Properties's sales growth this year is expected to be 3.4% and 4.5% for next year.

Year-on-year quarterly revenue growth grew by 8%, now sitting on 2.75B for the twelve trailing months.

Boston Properties's sales growth is 3.5% for the ongoing quarter and 8.9% for the next. The company's growth estimates for the present quarter and the next is 8.6% and 57.5%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 4.96%.

Volatility

Boston Properties's last day, week, and month's current intraday variation average was 0.51%, 1.21%, and 0.67%, respectively.

Boston Properties's highest amplitude of average volatility was 1.55% (day), 2.04% (last week), and 2.73% (last month), respectively.

Boston Properties's Stock Yearly Top and Bottom Value

Boston Properties's stock is valued at $113.70 at 07:23 EST, under its 52-week high of $124.24 and way higher than its 52-week low of $86.33.

Boston Properties's Moving Average

Boston Properties's worth is below its 50-day moving average of $114.79 and under its 200-day moving average of $114.65.

2. Oil (ODC)

66.24% Payout Ratio

Oil-Dri Corporation of America, together with its subsidiaries, develops, manufactures, and markets sorbent products in the United States and internationally.

Volume

Today's last reported volume for Oil is 53260, 300.6% above its average volume of 13295.

As claimed by Morningstar, Inc., the next dividend payment is on Nov 9, 2021, the estimated forward annual dividend rate is 1.08 and the estimated forward annual dividend yield is 3.09%.

Year-on-year quarterly revenue growth grew by 20.5%, now sitting on 304.98M for the twelve trailing months.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 7.15%.

Volatility

Oil's last day, week, and month's current intraday variation average was 0.10%, 2.19%, and 1.11%, respectively.

Oil's highest amplitude of average volatility was 3.46% (day), 3.75% (last week), and 2.41% (last month), respectively.

Oil's Stock Yearly Top and Bottom Value

Oil's stock is valued at $30.19 at 07:23 EST, way below its 52-week high of $38.45 and above its 52-week low of $29.64.

Oil's Moving Average

Oil's worth is way below its 50-day moving average of $34.36 and way below its 200-day moving average of $35.12.

3. Progress Software Corporation (PRGS)

38.46% Payout Ratio

Progress Software Corporation develops business applications.

Volume

Today's last reported volume for Progress Software Corporation is 27222, 92.88% below its average volume of 382569.

As claimed by Morningstar, Inc., the next dividend payment is on Nov 29, 2021, the estimated forward annual dividend rate is 0.7 and the estimated forward annual dividend yield is 1.46%.

Progress Software Corporation's sales growth this year is expected to be 20.7% and 11.1% for next year.

Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 513.57M for the twelve trailing months.

Progress Software Corporation's sales growth for the current quarter is 5.8%. The company's growth estimates for the ongoing quarter and the next is negative 18.7% and 3.2%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 21.22%.

Volatility

Progress Software Corporation's last day, week, and month's current intraday variation average was 0.19%, 2.52%, and 1.66%, respectively.

Progress Software Corporation's highest amplitude of average volatility was 2.10% (day), 3.60% (last week), and 2.92% (last month), respectively.

Progress Software Corporation's Stock Yearly Top and Bottom Value

Progress Software Corporation's stock is valued at $48.22 at 07:23 EST, way below its 52-week high of $53.99 and way above its 52-week low of $39.91.

Progress Software Corporation's Moving Average

Progress Software Corporation's worth is below its 50-day moving average of $50.00 and higher than its 200-day moving average of $46.75.

4. Cathay General Bancorp (CATY)

33.42% Payout Ratio

Cathay General Bancorp operates as the holding company for Cathay Bank that offers various commercial banking products and services to individuals, professionals, and small to medium-sized businesses in the United States.

Volume

Today's last reported volume for Cathay General Bancorp is 1465550, 371.89% above its average volume of 310565.

As claimed by Morningstar, Inc., the next dividend payment is on Aug 26, 2021, the estimated forward annual dividend rate is 1.24 and the estimated forward annual dividend yield is 2.78%.

Cathay General Bancorp's sales growth this year is expected to be 8% and 5.9% for next year.

Year-on-year quarterly revenue growth grew by 19.8%, now sitting on 652.88M for the twelve trailing months.

Cathay General Bancorp's sales growth is 11.2% for the present quarter and 9.3% for the next. The company's growth estimates for the ongoing quarter and the next is 28.2% and 1.1%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.15%.

Volatility

Cathay General Bancorp's last day, week, and month's current intraday variation average was 3.03%, 1.54%, and 1.60%, respectively.

Cathay General Bancorp's highest amplitude of average volatility was 3.11% (day), 2.96% (last week), and 2.95% (last month), respectively.

Cathay General Bancorp's Stock Yearly Top and Bottom Value

Cathay General Bancorp's stock is valued at $41.65 at 07:23 EST, way below its 52-week high of $46.43 and way higher than its 52-week low of $30.25.

Cathay General Bancorp's Moving Average

Cathay General Bancorp's worth is below its 50-day moving average of $43.25 and above its 200-day moving average of $41.12.

5. Franco (FNV)

30.51% Payout Ratio

Franco-Nevada Corporation operates as a gold-focused royalty and stream company in the United States, Canada, Latin America, Australia, Europe, and Africa, and internationally.

Volume

Today's last reported volume for Franco is 188562, 67.29% below its average volume of 576614.

As claimed by Morningstar, Inc., the next dividend payment is on Sep 14, 2021, the estimated forward annual dividend rate is 1.2 and the estimated forward annual dividend yield is 0.84%.

News about Franco (FNV) today

  • According to today's article on MarketWatch, "Terry Bradshaw's desperation pass deflected off either Oakland's Jack Tatum or Pittsburgh's Frenchy Fuqua to Franco Harris, who caught it at his shoe tops and ran in for a TD."

Franco's sales growth this year is anticipated to be 11.7% and 3.7% for next year.

Year-on-year quarterly revenue growth grew by 78.1%, now sitting on 1.24B for the twelve trailing months.

Franco's sales growth is 9.5% for the present quarter and negative 0.1% for the next. The company's growth estimates for the present quarter and the next is 12.5% and 4%. The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 12.46%.

Volatility

Franco's last day, week, and month's current intraday variation average was 0.52%, 0.34%, and 0.63%, respectively.

Franco's highest amplitude of average volatility was 1.75% (day), 1.55% (last week), and 2.19% (last month), respectively.

Franco's Stock Yearly Top and Bottom Value

Franco's stock is valued at $135.51 at 07:23 EST, way below its 52-week high of $163.79 and way above its 52-week low of $105.62.

Franco's Moving Average

Franco's worth is below its 50-day moving average of $139.39 and under its 200-day moving average of $140.93.

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com